GlaxoSmithKline Biologicals, Belgium
Pfizer, USA
Merck, USA
Novartis AG, Switzerland
Sanofi Pasteur, France
Sanofi-Aventis, France
MedImmune, USA
Baxter, USA
Novozymes A/S, Denmark
Wyeth, USA
Intercell, Austria
Crucell, Netherlands
VaxInnate, Inc., USA
Shenzhen Polytechnic, China
Medicago Inc, Canada
Novartis Vaccines, USA
Cyto Pulse Sciences, Inc., USA
GlaxoSmithKline Biologicals, USA
Selecta Biosciences Inc., USA
Petrovax Group, Russia
Becton,Dickinson&Company, USA
TechnoVax, USA
Antagen Biosciences, Inc., USA
Apogee Technology, Inc, USA
Acambis, UK
Chiron, USA
3M, USA
CSC, USA
AlphaVax, USA
Emergent BioSolutions, UK
Hawaii Biotech, USA
Arbovax, Inc, USA
PATH, USA
Sigma-Aldrich, USA
Duke-NUS, Singapore
TechnoVax, Inc., USA
Medicago Inc, Canada
Kotwal Bioconsulting, LLC, USA
MedImmune Vaccine, USA
Synergy America, Inc., USA
VPM Inc., Germany
Shanghai H&G Biotechnology Inc., China
Oxford-Emergent Tuberculosis Consortium Ltd, UK
Theraclone Sciences, Inc, USA
Green Cross Therapeutics Pvt Ltd, India
DanDrit Biotech, Denmark
Crossbeta Biosciences B.V., The Netherlands
Transgene S.A., France
TD Consultancy, LLC, USA
BioReliance, UK
Biosante Pharmaceuticals, USA
Vaxgen Corporation, USA
AXIO International, France
Charles River Avian Products and Services, USA
Strategic Manufacturing Worldwide, Inc., USA
GE Healthcare Life Sciences, Sweden
VTI Pharmaceutical Technologies (Shenzhen) Co., Ltd., China
GE Healthcare Life Sciences,China
Althea Technologies Inc., USA
immatics biotechnologies GmbH,Germany
Green Hills Biotechnology GmbH, Austria
Gan Shmuel, Israel
SIOGEN Biotech, Malaysia
OptiNose AS, Norway
Civimetrix, Canada
Apotex, Canada
Biovet Pvt Ltd, India
BD Technologies,



International Vaccine Institute
International AIDS Vaccine Institute
Global TB Vaccine Foundation
Bill & Melinda Gates Foundation, USA
Center for Disease Control and Prevention, China
Center for Disease Control and Prevention, USA
Children’s Global Health Initiative, USA
Vaccine and Infectious Disease Organization, Canada
Sabin Vaccine Institute, USA
National Institutes of Health , USA
National Human Genome Research, USA
National Vaccine and Serum Institute, China
Karolinska Institute, Sweden
Anderson Cancer Center, USA
Albert Einstein College of Medicine, USA
Oxford University, UK
Institute Pasteur, France
Tufts University, USA
Tufts University School of Medicine, USA
Fudan University, China
University of Missouri-Columbia, USA
Aarhus University Hospital – Skejby, Denmark
Baylor College of Medicine, USA
Fraunhofer USA CMB, USA
INSERM, France
Arizona State University, USA
Uppsala University. Sweden
US Army Medical Research Institute of Infectious Diseases, USA
Arizona State University, USA
University of Calgary, Canada
Gold Coast Campus, Australia
University of Calgary, Canada
National Health Research Institutes,Taiwan
Netherlands Vaccine Institute, Netherlands
Chungnam National University, Korea
The University of Sydney, Australia
Queen Mary University of London, UK
University of Lille2 and University of Artois, France
Ghent University, Belgium
Chicago Medical School, USA
National University of Colombia, Colombia
Army Medical Research Institute of Infectious Diseases, USA
European Commission Joint Research Center, Italy
University of Arkansas for Medical Sciences, USA
Mount Sinai School of Medicine, USA
University of New South Wales, Australia
Chinese Academy of Engineering, China
CrucellBerna Biotech Korea, Korea
Pomeranian Medical University, Poland
Public Health Service, The Netherlands
University of New South Wales, Australia
The Wistar Institute, USA
Kamineni Institute of Medical Sciences, India
RMIT University, Australia
National Taiwan University, Taiwan
University of Indonesia, Indonesia
World Health Organization, Switzerland
Russian Academy of Medical Sciences,Russian Federation
National Tsing Hua University, Taiwan
University of California, Davis, USA
Kuwait University, Kuwait
Lanzhou University, China
Texas Tech University Health Sciences Center, USA
Queensland Institute of Medical Research, Australia
French National Academy of Medicine, France
New York University, USA
Harvard Medical School, USA
Link?ping University, Sweden
D Cotugno Hospital, Italy
Chiang Mai University, Thailand
The Ohio State University, USA
Deakin University, Australia.
Vrije Universiteit Brussel, Belgium
University of Paris, France
University of Southampton, UK
University of Ulm, Germany
National Cancer Research Center, Serbia
World Health Organisation (WHO), Uganda
Cornell University, USA
Hacettepe University, Turkey
Tel Aviv University, Israe
National Institute of Hygiene, Morocco


 Submission Guidelines

1. The organizers of World Congress of Vaccine invite abstracts within the scope of the meeting. Submitted abstracts will be reviewed by experts and be scheduled for oral or poster presentation during the congress if the topic is relevant and the quality of the data justifies its scheduling. Irrelevant or poor-quality abstracts may be rejected.

2. Abstracts can only be submitted online via the congress website. It is advisable to prepare the complete abstract text and any figures/tables before accessing online abstract submission.

3. Abstracts need to written in clear English, taking into account the specifications below (see also sample on the button of this page):
a. Maximum words count abstract title: 50 words.

b. Maximum words count abstract text: 350 words (adjust in case of tables/figures).

c. Abstract topic should be selected during the online submission process from the list of predefined topics to facilitate abstract review and scheduling.

d. A minimum of three specific keywords should be added during online submission for indexing of the abstract. Specific keywords are: name(s) of drug(s) investigated, molecular target molecule(s), disease(s) studied, biochemical or biological function(s) studied. Avoid the use of non-specific keywords, such as: angiogenesis, cell death, cancer, tumor, drug development, drug therapy. The World Congress of Vaccine reserves the rights to delete, edit, or add keywords to achieve uniformity throughout abstract publications.

e. Use International Nonproprietary Names (INN) or research codes to identify drugs throughout the abstract. Proprietary names may be used in the abstract text, but the abstract title. It will be the first time for the drugs to be mentioned there. (put proprietary names between brackets).

f. The identity of a new, previously unpublished drug substance needs to be disclosed in the abstract, either by providing its structural formula or its full chemical name.

4. Abstracts will be published exactly as submitted. No editing of abstract texts will be done. However, non-adherence to the above guidelines may be corrected (e.g. use of drug names, keywords) by the meeting organizers.

5. After submission, abstracts cannot be changed by the authors anymore. Should minor changes be necessary after submission, the submitting author should notify the World Congress of Vaccine Secretariat by email, describing exactly the nature of the change to be made. The World Congress of Vaccine organizers will then implement the change. In case of major changes, the authors should submit a revised abstract as an entirely new abstract and request the World Congress of Vaccine Secretariat to delete the original abstract. The addition of a co-author constitutes a major change.

6. After completion of the abstract review, the submitting author will receive scheduling information via email. Abstracts cannot be withdrawn after receipt of the scheduling information by the submitting author. The presenting author must be registered as a World Congress of Vaccine participant for final scheduling and publication of the abstract.

7. Accepted abstracts will be published in the World Congress of Vaccine Proceedings, and in a (supplement to a) medical journal. Abstracts will not be released publicly before March 1, 2010.

Click here for the abstract sample

 

 
© 2009-2010 All right reserved for BIT Conferences
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629